The 2024 ASCO Annual Meeting, organized by the American Society of Clinical Oncology, is a key event funded through Conquer Cancer®, the ASCO Foundation with contributions from various sponsors. Major sponsorship levels include Platinum from Daiichi-Sankyo, Gold from Bristol Myers Squibb, and Silver from HELSINN. Additionally, prominent pharmaceutical companies like Merck & Co., Inc., AbbVie, Inc., AstraZeneca, Daiichi Sankyo, Inc., and Regeneron Pharmaceuticals, Inc. have contributed as Track Donors. This meeting is an essential gathering for oncology professionals to discuss advancements in cancer research and patient care. Details about the event’s specific dates, location, and registration costs were not provided. For more information, individuals are encouraged to contact ASCO directly at their headquarters in Alexandria, Virginia.